Cargando…
Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation
Background. Aidi injection (ADI) is an effective Traditional Chinese medicine preparation widely used for lung cancer. However, the pharmacological mechanisms of ADI on lung cancer remain to be elucidated. Methods. A network pharmacology (NP)-based approach and the molecular docking validation were...
Autores principales: | Zhuang, Zhenjie, Lin, Tong, Luo, Lixia, Zhou, Weixin, Wen, Junmao, Huang, Haifu, Liu, Zhanhua, Lin, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881165/ https://www.ncbi.nlm.nih.gov/pubmed/33506873 http://dx.doi.org/10.1042/BSR20204062 |
Ejemplares similares
-
A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
por: Zhuang, Zhenjie, et al.
Publicado: (2020) -
Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer
por: Zhang, Weizhou, et al.
Publicado: (2022) -
Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments
por: Wang, Haojia, et al.
Publicado: (2023) -
Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression
por: Lu, Yuan, et al.
Publicado: (2022) -
Durable Clinical Response of Advanced Lung Adenocarcinoma Harboring EGFR-19del/T790M/BRAF(V600E) Mutations After Treating with Osimertinib and Dabrafenib Plus Trametinib: A Case Report
por: Ding, Honggang, et al.
Publicado: (2020)